The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The stock dipped 8.5% to Rs 258 after reported a sharp 82% YoY decline in net profit at Rs 34 crore for June quarter.
The stock dipped 9% to Rs 510 after reported a sharp 82% YoY decline in net profit at Rs 1.48 crore in June quarter.
The company has implemented its Intellect Custody Solution in Commercial International Bank, Egypt.
The stock is up 3% at Rs 1,191, extending its previous day's 13% rally on the BSE.
The stock has appreciated by more than 100% thus far in 2015, compared to a 3% rise in the S&P BSE Sensex.
Renewed buying interest in ONGC and RIL coupled with gains in Vedanta is contributing to the rise on the Sensex
The company reported a 43% jump in consolidated net profit, on a sequential basis, at Rs 329 crore for the quarter ended June.
The stock was 5.4% at Rs 429, extending its previous day's 7% rally on the BSE.
Meanwhile, caution is likely to prevail on the bourses ahead of the US jobs data due later today
It recorded a net profit of Rs 211 crore as against a net profit of Rs 212 crore in the corresponding period last year
Provisionally, the Sensex closed at 28,312, higher by 89 points and the Nifty ended at 8,588, up 20 points
The textile company reported a net profit of Rs 26.38 crore in the June quarter against a loss of Rs 11.47 crore in the year-ago quarter.
The stock dipped 18% to Rs 2,030 in intra-day trade after reported a 28% YoY decline in net profit at Rs 5.05 crore in June quarter.
The stock touched a record high of Rs 356 in intra-day trades today and has zoomed by 26% in the past two days from Rs 282 on the BSE.
The stock surged 6% to Rs 129 after the company won the projects worth of around US $ 15 million.
Thus far in 2015, the stock has outperformed the market by surging 28% compared to a 2.6% rise in the Sensex till the previous trading session
Dr Reddy's Lab, Cipla, Lupin and Sun Pharma are trading higher between 0.7-2.7%
The stock dipped 13% to Rs 1,015 after reported 24% YoY drop in its consolidated net profit at Rs 14.06 in June quarter.
Since July 29, the stock has outperformed the market by surging 17% compared to 2.4% rise in CNX Nifty.
The stock moved higher by 7% to Rs 102, extending its previous day's 20% rally on the BSE.